East Asia

East Asia spans countries including China, Japan, South Korea, and Taiwan. This archive gathers reported milestones from the region — covering public health, environmental efforts, technology, and social progress. Each entry highlights specific, verifiable developments worth knowing about.

Japanese flag, for article on Japan abortion pill

Japan approves first abortion pill

By / / Good News For Humankind

Japan’s first abortion pill won approval in 2023, and clinical trials there showed 93% of participants had a complete abortion within 24 hours using the two-pill combination. Until that vote, Japan had been one of the last developed nations offering only surgical options, including a method the World Health Organization calls obsolete. The ministry took the unusual step of opening a public comment period before deciding, drawing strong responses from doctors and advocates who had pushed for years. The approval is historic, though spousal consent requirements still shape who can actually access care. As reproductive rights contract in some countries and expand in others, Japan’s shift is a reminder that progress is uneven, hard-won, and worth celebrating wherever it lands.

Seoul at night, for article on South Korea same-sex health insurance

South Korea court recognizes same-sex couple rights for first time

By / / Good News For Humankind

Same-sex health insurance benefits just won recognition in a South Korean court for the first time, in a case brought by So Seong-wook after the national insurer reversed his approved coverage as his partner’s dependent. The Seoul High Court ruled that denying spousal benefits to a same-sex couple was unlawful discrimination, with judges writing that being in the minority “cannot be wrong itself.” The decision doesn’t legalize same-sex marriage, but it reads existing law broadly enough to include same-sex partners in one of the most practical recognitions a state offers. In a country still without a legal framework for same-sex partnerships, that’s a meaningful crack in the wall — and a reminder that equality often arrives one plaintiff, one ruling at a time.

Aerial view of Shanghai traffic, for article on global EV sales

10% of global car sales were electric in 2022 for first time ever

By / / Good News For Humankind

Electric vehicles crossed a quiet but enormous threshold in 2022, making up one in every ten new cars sold worldwide for the first time. Roughly 7.8 million fully electric vehicles found buyers that year, even as overall car sales slipped. China led the charge, with EVs accounting for nearly a fifth of new cars sold there, while Europe wasn’t far behind at 11%. Behind the numbers is a deeper shift: battery prices have fallen dramatically over the past decade, and major automakers are doubling their EV output even as their broader sales decline. Ten percent is the moment a technology stops being niche and starts reshaping an industry — a hopeful signal for the global push toward cleaner transport.

DNA, for article on artificial DNA cancer

In a world first, Japenese scientists use artificial DNA to kill cancer cells

By / / Good News For Humankind

Artificial DNA that turns cancer’s own biology against itself marks a genuine conceptual leap in oncology. Japanese researchers at the University of Tokyo engineered synthetic molecules that lie dormant until they detect a chemical cancer cells overproduce — then restructure themselves into a signal the immune system reads as a threat, destroying the tumor from within. Early tests spanned multiple cancer types, suggesting broad potential. This kind of precision — working with the body’s existing defenses rather than overwhelming them — is exactly the direction cancer medicine has been reaching toward, and this research moves that goal meaningfully closer.